A recent report published by Infinium Global Research on rapid diagnostics market provides in-depth analysis of segments and sub-segments in global as well as regional rapid diagnostics market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional rapid diagnostics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global rapid diagnostics market. According to the report the global rapid diagnostics market is projected to grow at a CAGR of 8.3% over the forecast period of 2018-2024.
Depending on the usage of digital platforms, technological advancements have again begun in the past few years. Moreover, increasing focus on developing mobile apps which can support and communicate with portable diagnostic systems. However, the arrival of digital platforms are the trends anticipate to further drive the global rapid diagnostics market over the forecast period. There has been a rise of chronic disease extensively in the past few years such as influenza, HCV, HIV and tuberculosis along with the growing awareness regarding early diagnosis among the people is the key factor responsible for the growth of rapid diagnostics market across the globe. Moreover, increasing use of mobile apps and bedside diagnostic testing will further drive the growth of the global rapid diagnostics market over the forecast period.
The report on global rapid diagnostics market covers segments such as, product and application. On the basis of product the global rapid diagnostics market is categorized into OTC rapid diagnostics test and professional rapid diagnostics test. On the basis of application the global rapid diagnostics market is categorized into infectious diseases rapid diagnostics, blood glucose rapid diagnostics, pregnancy, and fertility rapid diagnostics, fecal occult blood rapid diagnostics, toxicology rapid diagnostics, cardiometabolic rapid diagnostics, and coagulation rapid diagnostics.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific the region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global rapid diagnostics market such as Abbott Diagnostics, Beckman Coulter, Bayer HealthCare, Eiken Chemical, Roche Diagnostics, Abaxis, Cepheid, Trivitron Healthcare, Bio-Rad Laboratories and Randox Laboratories.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global rapid diagnostics market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of rapid diagnostics market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the rapid diagnostics market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the rapid diagnostics market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter
Infinium Global Research © 2019 All Rights Reserved